Stock Market Today, March: CytomX Surges on Positive Data
CytomX Therapeutics delivered a sharp rally after promising Phase 1 data for its colorectal cancer program. This arti...
Learn the core crypto basics and the key holdings a beginner should own, plus tips to manage risk and start a balanced portfolio.
25,015 articlesCytomX Therapeutics delivered a sharp rally after promising Phase 1 data for its colorectal cancer program. This arti...
Explore how Solo Brands (SBDS) 2025 could unfold, with a clear view of revenue drivers, margins, and strategic bets. ...
Some job seekers chase every opening with a relentless grind. This story follows a candidate who applied 4,000 jobs w...
As recession fears swirl, long-duration U.S. Treasuries offer a potential ballast. The TLT ETF is drawing interest as...
Investors noticed a meaningful rebound in Jumia’s growth metrics, nudging the stock higher. This article breaks down ...
Sharplink's 2026 earnings path hinges on user growth, margins, and regulatory resilience. This guide breaks down the ...
Space stocks offer a compelling diversification away from AI hype. This guide explains why more these space stocks ma...
The Virtus InfraCap U.S. Preferred Stock ETF (PFFA) offers a 9.5% yield, backed by 188 holdings and modest leverage. ...
A leading U.S. health care powerhouse is quietly building an AI-driven engine that touches every corner of its busine...
Railroads still power the economy, and the big players like Union Pacific and CSX remain compelling for long-term inv...
DraftKings fights for growth across shifting state rules and expanding iGaming. This article breaks down what to watc...
In May, centrus energy stock sank after a positive start to the quarter. This article breaks down the core forces beh...